Cargando…
Performance of the G4 Xpert(®) MTB/RIF assay for the detection of Mycobacterium tuberculosis and rifampin resistance: a retrospective case-control study of analytical and clinical samples from high- and low-tuberculosis prevalence settings
BACKGROUND: The Xpert(®) MTB/RIF (Xpert) assay is a rapid PCR-based assay for the detection of Mycobacterium tuberculosis complex DNA (MTBc) and mutations associated with rifampin resistance (RIF). An updated version introduced in 2011, the G4 Xpert, included modifications to probe B and updated ana...
Autores principales: | Dharan, Nila J., Blakemore, Robert, Sloutsky, Alex, Kaur, Devinder, Alexander, Richard C., Ghajar, Minoo, Musser, Kimberlee A., Escuyer, Vincent E., Rowlinson, Marie-Claire, Crowe, Susanne, Laniado-Laborin, Rafael, Valli, Eloise, Nabeta, Pamela, Johnson, Pamela, Alland, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168809/ https://www.ncbi.nlm.nih.gov/pubmed/27993132 http://dx.doi.org/10.1186/s12879-016-2039-4 |
Ejemplares similares
-
Retrospective Diagnostic Accuracy Study of Abbott RealTime MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis and Susceptibility to Rifampin and Isoniazid Treatment
por: Howlett, Patrick, et al.
Publicado: (2021) -
Need to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible cases
por: Vadwai, Viral, et al.
Publicado: (2012) -
Tuberculosis Variant with Rifampin Resistance Undetectable by Xpert MTB/RIF, Botswana
por: Modongo, Chawangwa, et al.
Publicado: (2023) -
The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing
por: Chakravorty, Soumitesh, et al.
Publicado: (2017) -
GeneXpert MTB/RIF Version G4 for Identification of Rifampin-Resistant Tuberculosis in a Programmatic Setting
por: Osman, Muhammad, et al.
Publicado: (2014)